VILOXAZINE HCL IN THE TREATMENT OF ENDOGENOUS-DEPRESSION - A STANDARD (IMIPRAMINE) CONTROLLED CLINICAL-STUDY

  • 1 January 1982
    • journal article
    • research article
    • Vol. 43  (3) , 111-112
Abstract
In a 4 wk, double-blind clinical trial, 20 patients with endogenous depression were randomly assigned to treatment with either viloxazine or imipramine. Statistically significant improvement was observed on the Hamilton Psychiatric Rating Scales for Depression and Anxiety for both treatment groups. There were no differences between the 2 treatment groups in the type, incidence, or severity of treatment emergent symptoms. No medication-related abnormalities in clinical laboratory values occurred in either treatment group.

This publication has 0 references indexed in Scilit: